Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma

Clinical trial NCT01400672 · TERMINATED

Trial details

NCT number: NCT01400672
Sponsor: Masonic Cancer Center, University of Minnesota
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Intrinsic Pontine Glioma

Start date: 2012-07-17
Primary completion: 2016-03-07
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.